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Natural products (NPs) are an excellent source of biologically active molecules that provide many 
biologically biased features that enable innovative designing of synthetic compounds. NPs are 
characterized by high content of sp3-hybridized carbon atoms; oxygen; spiro, bridged, and linked 
systems; and stereogenic centers, with high structural diversity. To date, several approaches have been 
implemented for mapping and navigating into the chemical space of NPs to explore the different aspects 
of chemical space. The approaches providing novel opportunities to synthesize NP-inspired compound 
libraries involve NP-based fragments and ring distortion strategies. These methodologies allow access 
to areas of chemical space that are less explored, and consequently help to overcome the limitations in 
the use of NPs in drug discovery, such as lack of accessibility and synthetic intractability. In this review, 
we describe how NPs have recently been used as a platform for the development of diverse compounds 
with high structural and stereochemical complexity. In addition, we show developed strategies aiming 
to reengineer NPs toward the expansion of NP-based chemical space by fragment-based approaches and 
chemical degradation to yield novel compounds to enable drug discovery.
Keywords: Chemical space. Natural products. Ring distortion. Fragment-based drug discovery. Diversity-
oriented synthesis. Chemical degradation .
INTRODUCTION
Natural products (NPs) are considered an excellent 
source for the discovery and development of new drug 
molecules (Newman, Cragg, 2012) owing to their 
diversity in both structural features and molecular targets. 
NPs unveil opportunities for synthetic organic chemists 
to develop innovative synthetic strategies (Northrup, 
MacMillan, 2002; Sharpless et al., 1983) while navigating 
the natural chemical space, which is characterized by 
diversity and is clearly separated from synthetic libraries 
(Koch et al., 2005; Wetzel et al., 2007).
NPs have also received considerable attention owing 
to their wide presence in drugs (Newman, Cragg, 2012). 
The natural drug space includes pure unaltered NPs, semi-
synthetic compounds, and NP mimics. The reduction in the 
number of NP-based compounds observed in recent years 
has led to the search for alternative methods to explore NPs 
for accelerating innovation process in the search for new 
drug scaffolds, which could be potential drug candidates.
A significant number of natural drugs are available 
in the market, and the number of newer representatives 
is increasing, although at a slower pace. Approximately 
28% of all approved drugs are either NPs (15%) or 
NP derivatives (NPD, 13%) (Dias, Urban, Roessner, 
2012). However, the process of moving from target 
identification to lead generation is laborious, especially 
because chemical space is enormously large and cannot 
be exploited conclusively by means of synthetic efforts 
(Wetzel et al., 2011).
NP-based drugs need to meet their endpoints and 
demonstrate solid safety profiles. Despite all the endeavors 
of pharmaceutical industry, around nine out of every ten 
drug candidates fail to obtain approval, resulting in high 
cost of drug development (“CSDD-Tufts Center for the 
Study of Drug Development,” 2018). 
A new trend is the application of high-throughput 
screening (HTS) of large compound libraries, which allow 
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identification of multiple lead compounds to increase 
the chance of discovering a lead compound that can 
successfully reach the market. This method provides a 
picture of the contribution of phenotypic screening for the 
discovery of first-in-class small-molecule drugs (Swinney, 
Anthony, 2011).
NPD have the potential to yield novel drugs having 
improved pharmacokinetic properties and biological 
activities, which provide therapeutic benefits in treating 
diseases. 
Some examples of NPs as sources of drugs are 
shown in Figure 1. Acetylsalicylic acid (Aspirin): an anti-
inflammatory agent derived from salicin, which is isolated 
from the bark of the willow tree Salix alba L; (Dias, Urban, 
Roessner, 2012) dopamine: a neurotransmitter obtained 
from phenylethylisoquinoline alkaloid by hydroxylation 
of tyrosine to L-3,4-dihydroxyphenylalanine (DOPA) 
followed by decarboxylation; solifenacin used to treat 
overactive bladder is derived from tetrahydroisoquinoline 
and has additional functional groups on this ring; 
and topotecan: an anticancer drug derived from 
camptothecin and has additional hydroxyl and 1-N,N-
dimethylmethanamine groups (Ehrenworth, Peralta-
Yahya, 2017). Pure unaltered NPs (PUNP) include 
Yohimbine (an indole alkaloid), quinine (antimalarial 
therapeutic), the diterpene gibberellic acid (a plant 
hormone), and adrenosterone (steroid hormone) (Wetzel 
et al., 2011). 
With the exponential increase in the number of 
viable novel drug targets, the quality and availability of a 
specific library for biological campaigns is a major issue. 
Therefore, populating the chemical space with innovative 
chemotypes besides HTS is a challenging process to 
rationally find hits and leads. 
As an alternative, cheminformatic methods are 
useful to filter and select compounds. With the upcoming 
focus on virtual high throughput screening (vHTS), 
computational methods are being increasingly applied to 
accelerate drug discovery process (Wetzel et al., 2007; 
Subramaniam, Mehrotra, Gupta, 2008). 
FIGURE 1 - Examples of natural products (NP) as sources of drugs (blue rectangle) and NP-inspiring compounds (green rectangle).
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Considering the uniqueness of structural patterns 
available from NP libraries, correlation of innovative 
scaffolds with the evolutive ability to bind biological 
targets is still an inspiring library design to populate new 
areas of chemical space, with higher chances of achieving 
increased hit rates in biochemical and biological screening. 
The two types of NP-based drugs (NPD and PUNP) 
given in Figure 1, provide new opportunities to enhance 
the application of alternative strategies for drug discovery. 
NP-based drugs can be classified into different 
areas. For this review, we can classify NP-based drugs 
into fragment-like compounds with low molecular weight 
and complex scaffolds with high three-dimensionality and 
complexity.
Recent approaches use NP-derived fragments or 
fragment-based drug discovery (FBDD) to explore a large 
fraction of chemical space and to suggest simple metrics 
for assessing synthetic compounds for NP likeness (Over 
et al., 2013; Genis, Kirpichenok, Kombarov, 2012). 
Alternative and elegant synthesis of NP-inspired 
scaffolds is another area of increasing interest in recent 
years (Paciaroni et al., 2017; Balthaser et al., 2011; 
Mcleod et al., 2014), and it applies well-known strategies 
such as biology-oriented synthesis (BIOS) (Antonchick 
et al., 2013; Van Hattum, Waldmann, 2014; Svenda et al., 
2015) and diversity-oriented synthesis (DOS) (Schreiber, 
2009; Schreiber, 2000; Grossmann et al., 2014) to 
facilitate drug discovery. BIOS involves a hierarchical 
classification of bioactive compounds according to 
structural relationships and type of bioactivity, and 
selection of scaffolds of bioactive molecule classes as 
starting points for the synthesis of compound collections, 
with focus on diversity. DOS is considered an efficient 
method to achieve structural diversity along with structural 
complexity (Wetzel et al., 2011).
DOS includes “ring distortion” approach to 
chemically explore the available NPs containing a complex 
and fused ring system to expand focused libraries. Ring 
distortion involves the altering of complex ring systems 
through various chemical reactions that enable ring 
cleavage, expansion, rearrangement, and fusion. This 
method has started to gain attention recently (Huigens et 
al., 2013; Rafferty et al., 2014).
NP-derived fragments and ring-distortion strategies 
have the potential to identify drug candidates by accessing 
the unexplored chemical and biological spaces of NPs 
(Figure 2) (Crane et al., 2016). 
In this review, the strategies to reduce structural 
complexity or to introduce drastic structural modifications 
of NPs to obtain the desired biological parameters, such 
as potency or selectivity, are shown. 
Natural product‑derived fragments
FBDD is an emerging approach for efficient lead 
discovery. It has already been used in the development 
of three drugs: 1) ipilimumab (Yervoy; Bristol-Myers 
Squibb), a monoclonal antibody immunotherapy; 2) 
vemurafenib (Zelboraf; Daiichi Sankyo/Roche); and 3) 
dabrafenib (developed by GlaxoSmithKline), an oral 
small-molecule BRAF kinase inhibitor (Flaherty et al., 
2011).
FBDD, which is considered a complementary drug 
discovery strategy, involves the exploration of library of 
organic fragments and small molecules with low molecular 
weight as a starting point for the process. (Baker, 2013; 
Chen et al., 2014; Congreve et al., 2003; Erlanson, 
McDowell, O’Brien, 2004; Joseph-Mccarthy et al., 2013; 
Murray, Rees, 2009; Scott et al., 2012).
Over the years, FBDD has evolved to allow 
characterization of an ideal fragment from a set of criteria 
defined as the “Rule of 3” (Congreve et al., 2003): 
molecular mass <300 Da; up to three hydrogen bond 
donors and acceptors; and logP ≤ 3 (Congreve et al., 
2003). FBDD allows exploiting larger areas of chemical 
space in compounds having low molecular weight during 
the process of drug discovery. However, this approach 
usually does not represent the real bioactivity of the tested 
compounds owing to low affinity for the target (Scott et 
al., 2012). The possibility of adding functional groups 
FIGURE 2 - Approaches providing novel opportunities to 
synthesize natural product-inspired compound libraries.
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increases the chances of improving bioactivity, making 
FBDD a process with high success rate depending on the 
number of compounds tested initially (Figure 3).
One of the bottlenecks for the success of FBDD 
campaign is the quality of the tested libraries, which 
generally show the following features. 1) Structural 
diversity and molecular recognition: increased chance 
of binding to proteins with polar groups; 2) Synthetic 
accessibility: possibility of chemical modification aiming 
at the growth of the fragment; 3) Physico-chemical 
properties: adherence to Rule of 3; 4) Viable source: few 
steps in synthesis (≤4 reaction steps) from commercial 
reagents, natural abundant sources, or biotechnology; 
5) Structural organization: different three-dimensional 
shapes; 6) rotatable bonds: 0-3; and 7) Chiral centers: 
0-1. (Barelier et al., 2014; Blomberg et al., 2009; Boyd, 
Turnbull, Walse, 2012; Discovery, 2012; Fuller et 
al., 2016; Lucas et al., 2015; Mashalidis et al., 2013; 
Wassermann et al., 2013; Zhang, Zhao, 2016).
Combining NPs and fragment approaches for 
drug discovery is a complex process when trying to fit 
the properties described above. NP-derived fragments 
can be highly different from synthetic compounds, 
when structural features, design, and obtention of a 
library component are compared. (Genis, Kirpichenok, 
Kombarov, 2012; Austin et al., 2016; Over et al., 2012; 
Pascolutii et al., 2015; Prescher et al., 2017; Rodrigues 
et al., 2016).
A previous study examined the Dictionary of NPs 
(DNP) (Buckingham, 1995) and confirmed that the most 
frequent structural elements of NPs are characterized by 
a high content of sp3-hybridized carbon atoms; oxygen; 
spiro, bridged, and linked systems; and stereogenic 
centers, with high structural diversity (Genis, Kirpichenok, 
Kombarov, 2012; Lee, Schneider, 2001). Furthermore, 
NPs populate areas of chemical space not occupied 
by average synthetic molecules (Over et al., 2013). In 
contrast, synthetic libraries are mainly characterized 
by sp2-rich compounds, with high content of nitrogen, 
covering well-explored regions of chemical space with 
less diversity in structure and molecular properties (Genis, 
Kirpichenok, Kombarov, 2012; Thomas, Johannes, 
2011). This could lead to the selection of more structures 
belonging to the same chemical space (Cheshire, 2011).
Generally, the differences given above can be 
assumed when comparing synthesized fragments and NP-
based fragments, with focus on heteroatom distribution, 
number of rings, fraction of aromatic rings, degree of 
ring fusion, and degree of three-dimensionality. (Koch 
et al., 2005; Wetzel et al., 2007; Over et al., 2013; Genis, 
Kirpichenok, Kombarov, 2012; Feher, Schmidit, 2003; 
Ertl, Schuffenhauer, 2008; Zaid et al., 2010; Ertl, Roggo, 
Schuffenhauer, 2008; Rosén et al., 2009; Feher, Schmidt, 
2003; Grabowski, Schneider, 2007; Henkel et al., 1999; 
Lee, Schneider, 2001).
Another aspect to be considered is the source of 
fragment components. While synthetic fragments are 
usually obtained by feasible synthesis in few steps or 
from available commercial sources, (Murray, Rees, 2016) 
NP-derived fragments are obtained in diverse ways. 
The production and/or amount of pure compounds are 
not straightforward and depends on the strategy used. 
(Pascolutti et al., 2015; Over et al., 2013; Rodrigues et 
al., 2016).
It is possible to use NPs in FBDD in three main 
ways as shown in Figure 4. Fragment-derived NPs can 
be divided in two main groups: 1) Fragment-sized NPs, 
which are usually selected from available NPs based on 
FIGURE 3 - Evolutive process of vemurafenib discovery from a fragment starting point.
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fragment-like properties; and 2) NP-based fragments, 
which are designed or chemically derived from natural 
complex structures.
Different strategies have been described in the 
literature for using fragments derived from NPs to develop 
bioactive compounds successfully. 1. Fragment-sized 
NPs: it is possible to filter fragment-sized NPs from 
an NP library, and with this collection of compounds, 
chemical modifications or designing of fully synthetic new 
compounds can be initiated; 2. In silico fragmentation: 
In silico fragment generation from a defined collection 
of compounds, which will be obtained synthetically or 
from a commercial library; 3. High-molecular weight 
degradation: Chemical modifications of NPs that 
generally cleave the structure to generate a diverse library 
of compounds. Each strategy is described below with 
successful examples in literature. 
a) Fragment-sized natural products
The use of fragment-sized NPs is the most classic 
strategy. It involves isolation, synthesis, or acquisition of 
known compounds for screening or medicinal chemistry 
campaigns. In addition, this strategy can be used to design 
derivatives, which could be obtained by semi-synthesis or 
total synthesis. 
Artemisinin is a classic example (Figure 5-a) 
(Haynes, Vonwiller, 1994; Silva et al., 2015). For 
fragment-sized NPs, several examples can be found in 
the literature. Approximately 23% of all known NPs fit 
fragment-like properties. However, rational approaches 
involving the construction of a fragment library, followed 
by specific FBDD are not widespread.
The main characteristic of this library is fitting of 
fragment-like properties, while maintaining biological 
relevance and high degree of three-dimensionality, 
incorporating chirality and molecular flexibility to the 
compound collection, and populating diverse fractions of 
the chemical space, as expected for NPs.
A recent study described the use of fragment-sized 
NPs for target identification and hits discovery against 
Plasmodium falciparum (Vu et al., 2018). The group from 
SGC Toronto elegantly reported a strategy that involved 
screening of an in-house library containing 643 NPs 
(complying with, at least, five of the established criteria 
for fragment-like compounds (MW ≤ 250 Da, ALogP < 4, 
HBD ≤ 4, HBA ≤ 5, RB ≤ 6, %PSA < 45) against 62 
proteins using a native mass spectrometry (MS) approach 
that allowed detection of protein-ligand interactions. From 
this screening, it was observed that 32 proteins formed 
complexes with 96 hits. 
The next step involved testing the 96 compounds 
in vitro against asexual intraerythrocytic blood stage P. 
falciparum 3D7 (100 mM). From the cell-based assay, it 
was possible to calculate the IC50 for 24 compounds, with 
14 compounds showing IC50 values lower than 45 μM 
(Figure 5-b). 
In a similar approach, Ronald et al developed their 
own fragment collection by screening an in-house drug-
like NP library using established fragment-like properties 
(Figure 5-c). From the collection of 371 compounds, 
binding interactions of compounds with P. falciparum 
deoxyuridine 5′-triphosphate nucleotidohydrolase 
(PfdUTPase) was analyzed using electrospray ionization 
Fourier-transform ion cyclotron resonance mass 
FIGURE 4 - Classification and definitions of natural and non-natural compounds according to structural features and fragment-like 
properties.
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spectrometry (Vu et al., 2013). After selecting the 
effective binders and testing the ability to reduce viability 
of P. falciparum stage V gametocytes, it was possible 
to establish a clear correlation between biochemical 
and phenotypic assays and to highlight the potential 
antimalarial activity of the fragment-sized NP securinine.
Another useful application for fragment-sized NPs 
is biology-driven functionalization to fragment growth 
usually to enhance molecular properties and improve 
pharmacokinetics, solubility, and bioavailability of the 
parent natural fragment. For fragment-sized NPs, library 
diversity is also achievable and can enhance the quality 
of library for biological purposes. Lizos and collaborators 
at Novartis showed library development from a low-
molecular weight NP for synthesizing analogs without 
risky Michael acceptor portion as well as analogs with high 
three-dimensionality (Figure 6) (Prescher et al., 2017). 
b) Natural product-based fragments
The fragmentation of high-molecular weight NPs 
can be performed manually or by in silico approaches, 
and is characterized by dissecting complex structures to 
find scaffold patterns that can be obtained from in-house 
or commercial libraries or even by synthetic campaigns 
for biology studies (Pascolutti et al., 2015; Prescher et al., 
2017; Crane, Gademann, 2016). This approach tends to 
generate simpler compounds, however, without escaping 
from the properties of NP scaffolds, making structural 
diversity one of the most important features of FBDD. 
(Over et al., 2012).
FIGURE 5 - Different approaches for developing bioactive compounds from fragment-sized natural products.
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The development of fragment library based on NP 
structures can be oriented according to research interest 
and library features. In this regard, it is possible to describe 
two main strategies for working on high-molecular 
weight NPs to produce compounds fitting fragment-like 
properties: 1) virtual structure fragmentation followed 
by synthesis/acquisition, (Koch et al., 2005; Over et al., 
2012) and 2) semisynthetic degradation of NPs. (Prescher 
et al., 2017).
Examples of fragmentation of high-molecular 
weight NPs can be found in the literature, ranging from 
development of a large library of fragment derivatives by 
synthesizing or extracting simpler scaffolds to medicinal 
chemistry approaches. 
Using simpler NP-based scaffolds to develop 
bioactive compounds is a classic strategy that can be 
classified as FBDD approach. Recently, the Searcey 
group developed a hybrid of the high-molecular weight 
simocyclinone D8 with ciprofloxacin, using a spacer to 
link the antibiotic to the coumarin core inspired by the NP 
structure (Figure 7). (Austin et al., 2016).
In another approach, Danishefsky applied DOS 
to synthesize the macrolactone core of migrastatin and 
analogs showing improved properties of the structurally 
simplified related compounds (Figure 8). (Pascolutti et al., 
2015; Gaul et al., 2004; Njardarson et al., 2004).
Virtual fragmentation can be assessed by dissecting 
the structures of parent compounds (Figure 9), usually 
available in house libraries, commercial sources, or NP 
databases, using a “pseudo-retrosynthetic” approach 
(RECAP) (Rodrigues et al., 2016; Lewell et al., 1998) or a 
structural classification of NPs (SCONP) approach. (Koch 
et al., 2005) Other approaches with similar algorithms 
have different methods to dissect high-molecular weight 
NPs to develop a fragment library (Figure 9-d) (Over et 
al., 2012). Furthermore, it is possible to generate new 
fragments by in silico degradation. In this case, in silico 
reactions are applied to specific structures to generate a 
virtual products library (Figure 10) (Prescher et al., 2017). 
In these two approaches, target fragments are generated 
from a NP-guided compound library development 
approach and can be selected for chemical elaboration 
according to biology results.
The chemical degradation of NPs is a challenging 
process as it depends on the number of available 
compounds for semisynthetic exploration, number of steps 
required for generating fragments, elucidation of complex 
structure, and reactivity of highly functionalized NPs. 
Furthermore, this strategy leads to a highly diverse library 
of derivatives of NPs and is gaining special attention from 
the research community because of the opportunities it 
opens for drug discovery. This topic is explained in the 
following section. 
Ring‑distortion strategy
Substituted heterocycles are critical scaffolds 
for drug development and have received considerable 
attention owing to their wide existence in a myriad of 
NPs (Zhang, Song, Qin, 2011). When applying BIOS and 
FIGURE 6 - Fragment-sized natural product derivatization 
toward drug-like compounds.
FIGURE 7 - Fragment selection from natural products for developing new bioactive compounds.
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DOS with focus on fused ring systems from NPs, several 
notable biological discoveries have been made in diverse 
disease areas. (Svenda et al., 2015; Basu et al., 2011; 
Collins, ones, 2014).
In BIOS, biological relevance is the prime criterion 
for the selection of compound classes and scaffolds that 
inspire the synthesis of compound collections with high 
bioactivity. BIOS connects chemical and biological 
spaces, that is, protein structure similarity clusters and 
small-molecule compound collections through biological 
prevalidation. This extends well-beyond NPs and includes 
all compounds with known biological relevance. (Wetzel 
et al., 2011) Although BIOS offers relevant compounds, 
it demands more of chemistry, and may require the 
application of elaborate chemistry methods and demand 
multistep sequences. (Dandapani, Marcaurelle, 2010).
Alternatively, DOS can provide access to complex 
and diverse small molecules, thereby demonstrating 
great promise in modulating the activity of many targets 
that have largely been outside the purview of traditional 
compound collections (Dandapani, Marcaurelle, 2010). 
In addition, DOS is of great significance in both chemical 
and pharmaceutical fields (Wetzel et al., 2011).
A recent study (Liu et al., 2018) described a 
synthetic methodology for C-N bond formation based 
on Al(OTf)3-mediated cascade deprotection, cyclization, 
and ionic hydrogenation pathway. This method facilitates 
the synthesis of diverse heterocycles, including 
hexahydrophenoxazines, tetrahydroquinolines, indoline, 
hexahydrocarbazoles, and pyrrolidones. This strategy 
can be employed as a key step towards the formation of 
piracetam (an approved medication for the treatment of 
mental diseases), thus offering an alternative and non-toxic 
route to the traditional methods.
Another heterocycle present in many drugs is 
indole (Zhang, Song, Qin, 2011; Paciaroni et al., 2017; 
Osman, El-Samahy, 2000; Bromidge et al., 1998). This 
fused ring demonstrates diverse biological activities 
owing to the numerous biological targets that bind 
various indoles, making indole nucleus a privileged 
scaffold that occupies a notable and biologically relevant 
chemical space. 
An example of indole-containing NP is Yohimbine 
(Figure 11), which has a highly complex ring system fused 
to an indole nucleus (Paciaroni et al., 2017). However, the 
development of novel DOS and BIOS approaches remains 
FIGURE 8 - Selection and synthesis of antitumoral fragments derived from high-molecular weight natural products.
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a challenging task, demanding more efficient protocols for 
the production of heterocycles (Liu et al., 2018). 
The ring-distortion strategies offer an alternative 
to the classic means of drug discovery, including new 
compound isolation and semisynthetic NP modifications. 
They allow access to unexplored chemical space, which 
in turn provides the potential for new compound targets 
to be discovered (Rossiter et al., 2017). This methodology 
is useful to construct stereochemically complex and 
structurally diverse compounds from NPs. Ring-cleavage, 
ring-expansion, ring-fusion, and ring-rearrangement 
reactions can enable dramatic structural changes, as shown 
in Table I. 
To  demons t ra te  r ing-d i s to r t ion  s t ra tegy, 
(Figure 11-14) four of the most readily available and 
well-studied NPs were selected, including the alkaloids 
Yohimbine and quinine, the diterpene gibberellic acid, 
and the steroid adrenosterone.
FIGURE 9 - Virtual fragmentation by RECAP and SCONP approach (a and c); RECAP construction of a fragment library (b); and 
SCONP approach toward bioactive compound development (d).
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Diversifying Yohimbine
To develop an innovative strategy, the ring-distortion 
methodology involving Yohimbine as a platform was used 
to generate complex and diverse small molecules with 
unique and diverse molecular architectures (Paciaroni et al., 
2017). Figure 11 shows a tryptoline ring-distortion strategy 
that enabled the rapid synthesis of four complex and diverse 
compounds (A-D) from Yohimbine (Paciaroni et al., 2017).
For the rapid synthesis of sequences (diverse ring 
cleavage, ring fusion, and ring rearrangement) from 
Yohimbine, two known transformations were employed: 
cyanogen bromide ring cleavage with alcohols and 
transformation of Yohimbine into a spirooxindole-
containing scaffold (Paciaroni et al., 2017). A four-step 
oxidative rearrangement of Yohimbine afforded the ring-
rearranged spirooxindole form A. Owing to the synthetic 
utility of cyanogen bromide in ring cleavage reactions, the 
centrally positioned basic nitrogen was connected through 
the tryptoline sub-structure of Yohimbine to yield B-D.
By altering molecular topology and reorganizing the 
core structure via ring-rearrangement of Yohimbine-based 
scaffold, a new ring-distorted compound A was obtained, 
which showed anti-inflammatory activity. This clearly 
demonstrated the potential of ring-distortion strategies for 
the discovery of new biologically active small molecules. 
Diversifying quinine
The stereochemical complexity, diverse functionality 
(a tertiary amine, a secondary alcohol, an olefin, and 
a quinoline), and two discrete ring systems of quinine 
(Figure 12), (Huigens et al., 2013) make it amenable 
to selective ring-system distortion to produce diverse 
molecular scaffolds. 
The application of ring-distortion strategies in 
the synthesis of complex and diverse small molecules 
from quinine have followed the sequences between 
one- to five-step reactions, which allow the conversion 
of quinine to the four structures. The cleavage and 
FIGURE 10 - Virtual degradation toward fragment library development.
TABLE I - Ring-distortion strategies and structural changes
Ring-cleavage Ring-expansion Ring-fusion Ring-rearrangement
structural changes novel ring skeletons addition of constrained ring alters the molecular topology
new functional groups
Increase molecular volume 
shape
structural elements 
diversification
reorganize the core structure
Increase of flexibility and 
conformational freedom
An intermediate to ring-
cleavage reactions
Decrease of flexibility and 
conformational freedom Conformation changes
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fusion of quinuclidine ring occurs selectively at N1–C2 
using O-phenyl thionochloroformate to form S-alkyl 
thiocarbamate E as a single diastereomer. Olefination 
using Petasis reagent, followed by ring-closing metathesis 
affords F. N-oxidation of the intermediate quinoline using 
mCPBA, followed by rearrangement, chlorination with 
oxalyl chloride, and substitution with an amine yields 
G. Addition of isoamylmagnesium bromide leads to 
alkylation and hemiaminal ether formation to provide H 
(Huigens et al., 2013; Hergenrother et al., 2013).
In this review, one chemical step starting from 
quinine provided new functional groups that can be further 
diversified (compounds E and H) to enhance the inherent 
biological activity or to improve drug-like properties.
Quinine shows ring-cleavage and fusion strategies 
as the most utilized approaches. While the ring-cleavage 
approach increases flexibility and conformational freedom 
(compound G), the ring-fusion approach results in opposite 
FIGURE 11 - Ring distortion strategies to access yohimbine-based scaffolds.
FIGURE 12 - Ring-distortion strategies to access quinine-based scaffolds.
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effect by the simple addition of a new constrained ring to 
the ring system (compounds E, F, and H). Depending on 
the objectives, both ring strategies can improve the profile 
of small molecules as potential drugs. 
Diversifying the diterpene gibberellic acid
The diterpene gibberellic acid enables the selective 
and independent functionalization (Figure 13) of each 
ring of the core structure via various reactions that can 
distort the tetracyclic diterpene core with a fused lactone 
(Huigens et al., 2013; Hergenrother et al., 2013).
Employing three- to five-step reactions can convert 
gibberellic acid into the four structures I-L. Oxidative 
cleavage conditions using pyridinium chlorochromate were 
used to obtain I and J. A ring opening reaction produced 
K by intramolecular [4 + 2] cycloaddition. Subsequently, 
base-catalyzed lactone rearrangement produced L.
An intermediate of L showed anticancer activity 
against lymphoma, cervical, melanoma, lung, and breast 
cell lines. The dramatic reorganization of the core structure 
by ring rearrangement provided a new derivative with 
biological properties.
Diversifying adrenosterone
Adrenosterone comprises five contiguous stereo-
genic centers and four individual carbocyclic rings. In 
addition, this structurally complex steroidal framework is 
functionalized with an enone or ketone and an exocyclic 
double bond. These functional groups can be manipulated 
strategically to synthesize novel, diverse, and complex 
FIGURE 13 - Ring-distortion strategies to access gibberellic-based scaffolds.
chemical scaffolds (Huigens et al., 2013; Hergenrother 
et al., 2013).
Using the known chemical reactivity of these 
functional groups, two- or three-step reactions can be 
employed to convert adrenosterone into four structures 
(Figure 14, M-P). Applying a novel Schmidt reaction 
and synthetic elaboration (catalyzed by DMAP) yielded 
M and N. Oxidative cleavage of adrenosterone ring using 
NaIO4 and KMnO4 and further elaboration using Baeyer–
Villiger rearrangement or Schmidt reaction yielded O and 
P (Huigens et al., 2013). 
Ring expansion is an efficient method to form novel 
ring skeletons or as a prelude to ring-cleavage reactions 
as shown in Figure 14. Changing the molecular volume 
and shape can be useful in controlling the lipophilicity of 
small molecules for use as drugs, and as an initial point for 
the design of compounds inherently biased by biological 
success.
Concluding remarks
The novel approaches shown in this review 
demonstrate the main characteristics of NPs and provide 
an opportunity to explore compounds by different 
approaches. Besides molecular biology, chemical ecology, 
and biosynthesis-driven strategies, we described classic NP 
chemistry based on isolation-testing sequence for identifying 
good leads, as well as diversity-oriented approaches based 
on fragments and synthetic methodologies to expand the 
NP-based chemical space. 
Overall, the main advantage of fragments and ring 
distortion over the other available strategies is the ability 
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FIGURE 14 - Ring-distortion strategies to access adrenosterone-based scaffolds.
to rapidly generate novel chemotypes that enhance the 
quality of chemical libraries for biological screening and 
drug discovery from virtual technologies and synthetic 
campaigns. Taken together, these strategies have led to 
the identification of multiple biologically active NP-
derived compounds, thereby demonstrating the potential 
of ring-distortion approach to discover new biologically 
active compounds, (Paciaroni et al., 2017) and providing 
proof-of-concept for these methods (Rossiter et al., 2017). 
It is also possible to address diversity problems 
in screening libraries of small molecules that occupy 
biologically relevant chemical space in areas critical to 
human health. For medicinal chemists involved in the 
design of compound libraries, it is highly advisable to 
diversify the range of appropriate fragments derived 
from NPs, and these fragments can be incorporated in the 
molecular framework of the synthetic molecule. 
Only few studies have successfully explored these 
methods to date (Rossiter et al., 2017; Huigens et al., 2013; 
Ciardiello et al., 2017; Garcia, Drown, Hergenrother, 
2016). These studies provide an open opportunity for 
NP and medicinal chemists to populate different areas 
of chemical space and inspire to move beyond common 
scaffolds and identify more innovative structures for 
probing biological activity (Rossiter et al., 2017).
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